drugset / Trial / NCT00804843

Merck Carotid Atherosclerosis Trial (MK-0000-111)(COMPLETED)

NCT00804843

Phase 2 Completed 100 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will examine the effect of statin and niacin therapy on carotid plaque biomarkers

Timeline

Start
2009-04
Primary completion
2010-10
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 10 mg
Subject Atorvastatin Small molecule 80 mg
Subject Niacin Small molecule 2 g
Comparator Simvastatin Small molecule 10 mg
Comparator Simvastatin Small molecule 80 mg

Indications